Education
About Us
Working with TipRanks
Follow Us
Actinogen Medical Limited (AU:ACW)
:ACW
Total Valuation
Actinogen Medical has a market cap or net worth of AU$181.41M. The enterprise value is AU$59.83M.
Market CapAU$181.41M
Enterprise ValueAU$59.83M
Share Statistics
Actinogen Medical has 3,182,577,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,182,577,100
Owned by Insiders6.70%
Owned by Institutions―
Financial Efficiency
Actinogen Medical ’s return on equity (ROE) is -0.80 and return on invested capital (ROIC) is -43.37%.
Return on Equity (ROE)-0.80
Return on Assets (ROA)-0.60
Return on Invested Capital (ROIC)-43.37%
Return on Capital Employed (ROCE)-0.81
Revenue Per Employee10.00T>
Profits Per Employee―
Employee Count―
Asset Turnover0.22
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Actinogen Medical is ―. Actinogen Medical ’s PEG ratio is 0.25.
PE Ratio―
PS Ratio12.48
PB Ratio3.74
Price to Fair Value3.74
Price to FCF-9.03
Price to Operating Cash Flow-16.91
PEG Ratio0.25
Income Statement
In the last 12 months, Actinogen Medical had revenue of 5.49M and earned -14.73M in profits. Earnings per share was 0.00.
Revenue5.49M
Gross Profit5.49M
Operating Income-14.93M
Pretax Income-14.73M
Net Income-14.73M
EBITDA-15.01M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -7.56M and capital expenditures -38.02K, giving a free cash flow of -7.59M billion.
Operating Cash Flow-7.56M
Free Cash Flow-7.59M
Free Cash Flow per Share>-0.01
Dividends & Yields
Actinogen Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.04
52-Week Price Change76.67%
50-Day Moving Average0.04
200-Day Moving Average0.03
Relative Strength Index (RSI)53.79
Average Volume (3m)5.60M
Important Dates
Actinogen Medical upcoming earnings date is Feb 19, 2026, TBA (Confirmed).
Last Earnings DateAug 25, 2025
Next Earnings DateFeb 19, 2026
Ex-Dividend Date―
Financial Position
Actinogen Medical as a current ratio of 3.76, with Debt / Equity ratio of 17.80%
Current Ratio3.76
Quick Ratio3.76
Debt to Market Cap0.04
Net Debt to EBITDA0.88
Interest Coverage Ratio-305.42
Taxes
In the past 12 months, Actinogen Medical has paid -5.49M in taxes.
Income Tax-5.49M
Effective Tax Rate0.37
Enterprise Valuation
Actinogen Medical EV to EBITDA ratio is -3.68, with an EV/FCF ratio of -7.28.
EV to Sales10.07
EV to EBITDA-3.68
EV to Free Cash Flow-7.28
EV to Operating Cash Flow-7.32
Balance Sheet
Actinogen Medical has AU$16.50M in cash and marketable securities with AU$3.26M in debt, giving a net cash position of AU$13.24M billion.
Cash & Marketable SecuritiesAU$16.50M
Total DebtAU$3.26M
Net CashAU$13.24M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 96.31%, with operating margin of -272.01%, and net profit margin of -268.37%.
Gross Margin96.31%
Operating Margin-272.01%
Pretax Margin-268.37%
Net Profit Margin-268.37%
EBITDA Margin-273.48%
EBIT Margin-279.70%
Analyst Forecast
The average price target for Actinogen Medical is AU$0.08, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$0.08
Price Target Upside50.92% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast10.91%